| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB7
|
ATP-binding cassette, sub-family B (MDR/TAP), member 7
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGK
|
acylglycerol kinase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHCYL1
|
adenosylhomocysteinase-like 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP4
|
A kinase (PRKA) anchor protein 4
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
ALS2CL
|
ALS2 C-terminal like
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD26
|
ankyrin repeat domain 26
|
|
ANKS1A
|
ankyrin repeat and sterile alpha motif domain containing 1A
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APC
|
adenomatous polyposis coli
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARHGAP22
|
Rho GTPase activating protein 22
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ATAD3A
|
ATPase family, AAA domain containing 3A
|
|
ATAD3B
|
ATPase family, AAA domain containing 3B
|
|
ATAD3C
|
ATPase family, AAA domain containing 3C
|
|
ATAT1
|
alpha tubulin acetyltransferase 1
|
|
ATL1
|
atlastin GTPase 1
|
|
ATL3
|
atlastin GTPase 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
ATXN7
|
ataxin 7
|
|
AVP
|
arginine vasopressin
|
|
AXIN2
|
axin 2
|
|
B9D1
|
B9 protein domain 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BCO1
|
beta-carotene oxygenase 1
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BEX2
|
brain expressed X-linked 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIN3
|
bridging integrator 3
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BRWD3
|
bromodomain and WD repeat domain containing 3
|
|
BSG
|
basigin (Ok blood group)
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C5AR2
|
complement component 5a receptor 2
|
|
C8ORF4
|
chromosome 8 open reading frame 4
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CASR
|
calcium-sensing receptor
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC26
|
CCDC26 long non-coding RNA
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CD14
|
CD14 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD63
|
CD63 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC5L
|
cell division cycle 5-like
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH23
|
cadherin-related 23
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELF6
|
CUGBP, Elav-like family member 6
|
|
CENPA
|
centromere protein A
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CEP41
|
centrosomal protein 41kDa
|
|
CFD
|
complement factor D (adipsin)
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGGBP1
|
CGG triplet repeat binding protein 1
|
|
CHCHD3
|
coiled-coil-helix-coiled-coil-helix domain containing 3
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRFAM7A
|
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHTF8
|
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae)
|
|
CIC
|
capicua transcriptional repressor
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLDN23
|
claudin 23
|
|
CLDN7
|
claudin 7
|
|
CLEC2A
|
C-type lectin domain family 2, member A
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNNM2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
|
CNNM4
|
cyclin and CBS domain divalent metal cation transport mediator 4
|
|
CNTN1
|
contactin 1
|
|
COCH
|
cochlin
|
|
COG1
|
component of oligomeric golgi complex 1
|
|
COG3
|
component of oligomeric golgi complex 3
|
|
COG5
|
component of oligomeric golgi complex 5
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPD
|
carboxypeptidase D
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CUL5
|
cullin 5
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAD1P1
|
defender against cell death 1 pseudogene 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCN
|
decorin
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNAJC11
|
DnaJ (Hsp40) homolog, subfamily C, member 11
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD3
|
dopamine receptor D3
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DST
|
dystonin
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE2
|
endothelin converting enzyme 2
|
|
EDARADD
|
EDAR-associated death domain
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EHF
|
ets homologous factor
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ELP4
|
elongator acetyltransferase complex subunit 4
|
|
EMP1
|
epithelial membrane protein 1
|
|
EN2
|
engrailed homeobox 2
|
|
ENG
|
endoglin
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA8
|
EPH receptor A8
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPYC
|
epiphycan
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC6L2
|
excision repair cross-complementation group 6-like 2
|
|
ERH
|
enhancer of rudimentary homolog (Drosophila)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
EVL
|
Enah/Vasp-like
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FAM161A
|
family with sequence similarity 161, member A
|
|
FAM20C
|
family with sequence similarity 20, member C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN2
|
fibulin 2
|
|
FBN1
|
fibrillin 1
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FERMT1
|
fermitin family member 1
|
|
FERMT2
|
fermitin family member 2
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FIZ1
|
FLT3-interacting zinc finger 1
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNTB
|
farnesyltransferase, CAAX box, beta
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA2
|
forkhead box A2
|
|
FOXC1
|
forkhead box C1
|
|
FOXE3
|
forkhead box E3
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRMD7
|
FERM domain containing 7
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUS
|
FUS RNA binding protein
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT5
|
fucosyltransferase 5 (alpha (1,3) fucosyltransferase)
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GAS7
|
growth arrest-specific 7
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAS
|
GNAS complex locus
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN3B
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GUCY2F
|
guanylate cyclase 2F, retinal
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNP1
|
Hypertensive nephropathy
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOOK3
|
hook microtubule-tethering protein 3
|
|
HOXA10
|
homeobox A10
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGES
|
immunoglobulin E concentration, serum
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
IMMT
|
inner membrane protein, mitochondrial
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISCA1
|
iron-sulfur cluster assembly 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITSN1
|
intersectin 1 (SH3 domain protein)
|
|
JAK2
|
Janus kinase 2
|
|
KCMF1
|
potassium channel modulatory factor 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNH7
|
potassium channel, voltage gated eag related subfamily H, member 7
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KERA
|
keratocan
|
|
KIFC1
|
kinesin family member C1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KIZ
|
kizuna centrosomal protein
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLHL14
|
kelch-like family member 14
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LBH
|
limb bud and heart development
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LIF
|
leukemia inhibitory factor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIN7B
|
lin-7 homolog B (C. elegans)
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LMNB2
|
lamin B2
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPCAT3
|
lysophosphatidylcholine acyltransferase 3
|
|
LRFN5
|
leucine rich repeat and fibronectin type III domain containing 5
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LUM
|
lumican
|
|
LZTS2
|
leucine zipper, putative tumor suppressor 2
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAOA
|
monoamine oxidase A
|
|
MAP1S
|
microtubule-associated protein 1S
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12
|
|
MAP3K15
|
mitogen-activated protein kinase kinase kinase 15
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1
|
|
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD3
|
methyl-CpG binding domain protein 3
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MBP
|
myelin basic protein
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCIDAS
|
multiciliate differentiation and DNA synthesis associated cell cycle protein
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCPH1
|
microcephalin 1
|
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MIR1290
|
microRNA 1290
|
|
MIR135A1
|
microRNA 135a-1
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR15A
|
microRNA 15a
|
|
MIR17
|
microRNA 17
|
|
MIR192
|
microRNA 192
|
|
MIR335
|
microRNA 335
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR377
|
microRNA 377
|
|
MIR584
|
microRNA 584
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKS1
|
Meckel syndrome, type 1
|
|
MLH1
|
mutL homolog 1
|
|
MLPH
|
melanophilin
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRAS
|
muscle RAS oncogene homolog
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MSX1
|
msh homeobox 1
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT1X
|
metallothionein 1X
|
|
MTERF1
|
mitochondrial transcription termination factor 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTSS1L
|
metastasis suppressor 1-like
|
|
MTX1
|
metaxin 1
|
|
MTX2
|
metaxin 2
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYLK
|
myosin light chain kinase
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NBN
|
nibrin
|
|
NCAPD3
|
non-SMC condensin II complex, subunit D3
|
|
NCAPG2
|
non-SMC condensin II complex, subunit G2
|
|
NCAPH2
|
non-SMC condensin II complex, subunit H2
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NCSTN
|
nicastrin
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMS
|
neuromedin S
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOL11
|
nucleolar protein 11
|
|
NOLC1
|
nucleolar and coiled-body phosphoprotein 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX3
|
NADPH oxidase 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPY
|
neuropeptide Y
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRXN3
|
neurexin 3
|
|
NTN1
|
netrin 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUCB2
|
nucleobindin 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUF2
|
NUF2, NDC80 kinetochore complex component
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP88
|
nucleoporin 88kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
NYX
|
nyctalopin
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OBFC1
|
oligonucleotide/oligosaccharide-binding fold containing 1
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
ORC3
|
origin recognition complex, subunit 3
|
|
OSBPL9
|
oxysterol binding protein-like 9
|
|
OSM
|
oncostatin M
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAAF1
|
proteasomal ATPase-associated factor 1
|
|
PANK1
|
pantothenate kinase 1
|
|
PANK2
|
pantothenate kinase 2
|
|
PANK3
|
pantothenate kinase 3
|
|
PAPD4
|
PAP associated domain containing 4
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PBRM1
|
polybromo 1
|
|
PBX4
|
pre-B-cell leukemia homeobox 4
|
|
PCAT1
|
prostate cancer associated transcript 1 (non-protein coding)
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCM1
|
pericentriolar material 1
|
|
PCNT
|
pericentrin
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PEX11B
|
peroxisomal biogenesis factor 11 beta
|
|
PF4V1
|
platelet factor 4 variant 1
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHF6
|
PHD finger protein 6
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PICK1
|
protein interacting with PRKCA 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKN3
|
protein kinase N3
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLEK
|
pleckstrin
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
PLEKHM1
|
pleckstrin homology domain containing, family M (with RUN domain) member 1
|
|
PLP1
|
proteolipid protein 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PLXDC2
|
plexin domain containing 2
|
|
PLXND1
|
plexin D1
|
|
PML
|
promyelocytic leukemia
|
|
PODXL
|
podocalyxin-like
|
|
POLM
|
polymerase (DNA directed), mu
|
|
POLR1C
|
polymerase (RNA) I polypeptide C, 30kDa
|
|
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa
|
|
POMC
|
proopiomelanocortin
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R8
|
protein phosphatase 1, regulatory subunit 8
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM16
|
PR domain containing 16
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PRPF19
|
pre-mRNA processing factor 19
|
|
PRPF3
|
pre-mRNA processing factor 3
|
|
PRSS8
|
protease, serine, 8
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PSEN1
|
presenilin 1
|
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTN
|
pleiotrophin
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PYCARD
|
PYD and CARD domain containing
|
|
QTRT1
|
queuine tRNA-ribosyltransferase 1
|
|
QTRTD1
|
queuine tRNA-ribosyltransferase domain containing 1
|
|
RAB10
|
RAB10, member RAS oncogene family
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB3GAP1
|
RAB3 GTPase activating protein subunit 1 (catalytic)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51C
|
RAD51 paralog C
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RCN2
|
reticulocalbin 2, EF-hand calcium binding domain
|
|
RECQL4
|
RecQ protein-like 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila)
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOV
|
ras homolog family member V
|
|
RINL
|
Ras and Rab interactor-like
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF113A
|
ring finger protein 113A
|
|
RNF146
|
ring finger protein 146
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPN2
|
ribophorin II
|
|
RPS3
|
ribosomal protein S3
|
|
RS1
|
retinoschisin 1
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RTN1
|
reticulon 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100B
|
S100 calcium binding protein B
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
|
SAMM50
|
SAMM50 sorting and assembly machinery component
|
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCG3
|
secretogranin III
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEPN1
|
selenoprotein N, 1
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHH
|
sonic hedgehog
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC24A1
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1
|
|
SLC25A5P8
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 pseudogene 8
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SLURP1
|
secreted LY6/PLAUR domain containing 1
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORBS1
|
sorbin and SH3 domain containing 1
|
|
SORT1
|
sortilin 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPPL2A
|
signal peptide peptidase like 2A
|
|
SPPL3
|
signal peptide peptidase like 3
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRGN
|
serglycin
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAB1
|
stabilin 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STK11
|
serine/threonine kinase 11
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STX4
|
syntaxin 4
|
|
STXBP5L
|
syntaxin binding protein 5-like
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
SUPT4H1
|
suppressor of Ty 4 homolog 1 (S. cerevisiae)
|
|
SUPT5H
|
suppressor of Ty 5 homolog (S. cerevisiae)
|
|
SUPT6H
|
suppressor of Ty 6 homolog (S. cerevisiae)
|
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2
|
|
SYT13
|
synaptotagmin XIII
|
|
TAAR6
|
trace amine associated receptor 6
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D20
|
TBC1 domain family, member 20
|
|
TBCE
|
tubulin folding cofactor E
|
|
TBPL1
|
TBP-like 1
|
|
TBX1
|
T-box 1
|
|
TBX2
|
T-box 2
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TEN1
|
TEN1 CST complex subunit
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLN1
|
talin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM59
|
transmembrane protein 59
|
|
TMPO
|
thymopoietin
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRB
|
T cell receptor beta locus
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM35
|
tripartite motif containing 35
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TXNL4B
|
thioredoxin-like 4B
|
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UHMK1
|
U2AF homology motif (UHM) kinase 1
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
UTRN
|
utrophin
|
|
UVSSA
|
UV-stimulated scaffold protein A
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VENTX
|
VENT homeobox
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VSX2
|
visual system homeobox 2
|
|
VWF
|
von Willebrand factor
|
|
WDR6
|
WD repeat domain 6
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAR1
|
zygote arrest 1
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNF24
|
zinc finger protein 24
|
|
ZNF521
|
zinc finger protein 521
|
|
ZPLD1
|
zona pellucida-like domain containing 1
|
